Evidence for the role of EPHX2 gene variants in anorexia nervosa

Molecular Psychiatry

Volumn 19, Issue 6, 2014, Pages 724-732

  Scott Van Zeeland, A A ^a,b   Bloss, C S ^a,b   Tewhey, R ^b,c   Bansal, V ^a,b   Torkamani, A ^a,b,c   Libiger, O ^a,c   Duvvuri, V ^d   Wineinger, N ^a,b   Galvez, L ^a   Darst, B F ^a,b   Smith, E N ^d   Carson, A ^a,b   Pham, P ^a,b   Phillips, T ^a,b   Villarasa, N ^a,b   Tisch, R ^a,b   Zhang, G ^a,b   Levy, S ^a,b,c   Murray, S ^a,b,c   Chen, W ^e   Srinivasan, S ^e   Berenson, G ^e   Brandt, H ^f   Crawford, S ^f   Crow, S ^g   Fichter, M M ^h   Halmi, K A ⁱ   Johnson, C ^j   Kaplan, A S ^k,l,m   La Via, M ⁿ   Mitchell, J E ^o,p   Strober, M ^q   Rotondo, A ^r   Treasure, J ^s   Woodside, D B ^l,m,t   Bulik, C M ^n,u   Keel, P ^t   Klump, K L ^v   Lilenfeld, L ^w   Plotnicov, K ^x   Topol, E J ^a,b,c   Shih, P B ^d   Magistretti, P ^y   Bergen, A W ^z   Berrettini, W ^aa   Kaye, W ^d   Schork, N J ^a,b,c   more..

^a SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^b SCRIPPS HEALTH   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e TULANE UNIVERSITY   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h Roseneck Hospital for Behavioral Medicine   (Germany)

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

^j Eating Recovery Center   (United States)

^k CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^l TORONTO GENERAL HOSPITAL   (Canada)

^m UNIVERSITY OF TORONTO   (Canada)

ⁿ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^o NEUROPSYCHIATRIC RESEARCH INSTITUTE   (United States)

^p UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r UNIVERSITY OF PISA   (Italy)

^s UNIVERSITY OF LONDON   (United Kingdom)

^t FLORIDA STATE UNIVERSITY   (United States)

^u University of North Carolina at Chapel Hill   (United States)

^v MICHIGAN STATE UNIVERSITY   (United States)

^w American School of Professional Psychology at Argosy University   (United States)

^x UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^y UNIVERSITY OF LAUSANNE   (Switzerland)

^z SRI INTERNATIONAL   (United States)

^aa UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

anorexia nervosa; EPHX2; genomics; hyperlipidemia; pooling; sequencing

Indexed keywords

CHOLESTEROL; EPOXIDE HYDROLASE; EPOXIDE HYDROLASE 2; ESTROGEN RECEPTOR BETA; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; EPHX2 PROTEIN, HUMAN;

ANOREXIA NERVOSA; ARTICLE; BODY MASS; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA REPLICATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL SCALING; POPULATION DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL; REPLICATION STUDY; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; EPOXIDE HYDROLASE 2 GENE; ESTROGEN RECEPTOR BETA GENE; GENE; GENE LOCUS; GENE SEQUENCE; CASE CONTROL STUDY; CAUCASIAN; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PSYCHOMETRY; YOUNG ADULT;

ADULT; ANOREXIA NERVOSA; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; COHORT STUDIES; EPOXIDE HYDROLASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOMETRICS; YOUNG ADULT;

EID: 84901258591     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2013.91     Document Type: Article

References (73)

1. Dalle Grave R. Eating disorders: progress and challenges. Eur J Intern Med 2011; 22: 153-160.
2. Kaye WH, Fudge JL, Paulus M. New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci 2009; 10: 573-584.
3. Wade TD, Bulik CM, Neale M, Kendler KS. Anorexia nervosa and major depression: shared genetic and environmental risk factors. Am J Psychiatry 2000; 157: 469-471.
4. Klump KL, Miller KB, Keel PK, McGue M, Iacono WG. Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample. Psychol Med 2001; 31: 737-740.
5. Kortegaard LS, Hoerder K, Joergensen J, Gillberg C, Kyvik KO. A preliminary population-based twin study of self-reported eating disorder. Psychol Med 2001; 31: 361-365.
6. Bulik CM, Sullivan PF, Tozzi F, Furberg H, Lichtenstein P, Pedersen NL. Prevalence, heritability, and prospective risk factors for anorexia nervosa. Arch Gen Psychiatry 2006; 63: 305-312.
7. Lilenfeld LR, Kaye WH, Greeno CG, Merikangas KR, Plotnicov K, Pollice C et al. A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity. Arch Gen Psychiatry 1998; 55: 603-610.
8. Strober M, Freeman R, Lampert C, Diamond J, Kaye W. Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes. Am J Psychiatry 2000; 157: 393-401.
9. Wang K, Zhang H, Bloss CS, Duvvuri V, Kaye W, Schork NJ et al. A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. Mol Psychiatry 2011; 16: 949-959.
10. Grice DE, Halmi KA, Fichter MM, Strober M, Woodside DB, Treasure JT et al. Evidence for a susceptibility gene for anorexia nervosa on chromosome 1. Am J Hum Genet 2002; 70: 787-792.
11. Bulik CM, Slof-Op't Landt MC, van Furth EF, Sullivan PF. The genetics of anorexia nervosa. Annu Rev Nutr 2007; 27: 263-275.
12. Bloss CS, Berrettini W, Bergen AW, Magistretti P, Duvvuri V, Strober M et al. Genetic association of recovery from eating disorders: the role of GABA receptor SNPs. Neuropsychopharmacology 2011; 36: 2222-2232.
13. Girirajan S, Brkanac Z, Coe BP, Baker C, Vives L, Vu TH et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 2011; 7: e1002334.
14. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011; 43: 838-846.
15. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012; 17: 142-153.
16. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539-543.
17. McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009; 41: 1223-1227.
18. Vacic V, McCarthy S, Malhotra D, Murray F, Chou HH, Peoples A et al. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 2011; 471: 499-503.
19. Root TL, Szatkiewicz JP, Jonassaint CR, Thornton LM, Pinheiro AP, Strober M et al. Association of candidate genes with phenotypic traits relevant to anorexia nervosa. Eur Eat Disord Rev 2011; 19: 487-493.
20. Pinheiro AP, Bulik CM, Thornton LM, Sullivan PF, Root TL, Bloss CS et al. Association study of 182 candidate genes in anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 1070-1080.
21. Schork NJ, Murray SS, Frazer KA, Topol EJ. Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 2009; 19: 212-219.
22. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ et al. Finding the missing heritability of complex diseases. Nature 2009; 461: 747-753.
23. Frazer KA, Murray SS, Schork NJ, Topol EJ. Human genetic variation and its contribution to complex traits. Nat Rev Genet 2009; 10: 241-251.
24. Smith EN, Chen W, Kahonen M, Kettunen J, Lehtimaki T, Peltonen L et al. Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart study. PLoS Genet 2010; 6: e1001094.
25. Jones AR, Overly CC, Sunkin SM. The Allen Brain Atlas: 5 years and beyond. Nat Rev Neurosci 2009; 10: 821-828.
26. Hawrylycz M, Ng L, Page D, Morris J, Lau C, Faber S et al. Multi-scale correlation structure of gene expression in the brain. Neural Netw 2011; 24: 933-942.
27. Cloninger CR. The Temperament and Character Inventory (TCI): A Guide to its Development and Use. Washington University: St Louis, MO, USA, 1994.
28. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
29. Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs AG. Manual for the State-Trait Anxiety Inventory (Form Y). Consulting Psychologists Press Incorporated: Palo Alto, 1983.
30. Mazure CM, Halmi KA, Sunday SR, Romano SJ, Einhorn AM. The Yale-Brown- Cornell Eating Disorder Scale: development, use, reliability and validity. J Psychiatr Res 1994; 28: 425-445.
31. Fichter M, Quadflieg N. The structured interview for anorexic and bulimic disorders for DSM-IV and ICD-10 (SIAB-EX): reliability and validity. Eur Psychiatry 2001; 16: 38-48.
32. 1000 Genomes Consortium. A map of human genome variation from populationscale sequencing. Nature 2010; 467: 1061-1073.
33. Tewhey R, Nakano M, Wang X, Pabon-Pena C, Novak B, Giuffre A et al. Enrichment of sequencing targets from the human genome by solution hybridization. Genome Biol 2009; 10: R116.
34. Homer N, Merriman B, Nelson SF. BFAST: an alignment tool for large scale genome resequencing. PLoS One 2009; 4: e7767.
35. Bansal V. A statistical method for the detection of variants from next-generation resequencing of DNA pools. Bioinformatics 2010; 26: i318-i324.
36. Levy S, Sutton G, Ng PC, Feuk L, Halpern AL, Walenz BP et al. The diploid genome sequence of an individual human. PLoS Biol 2007; 5: e254.
37. Bansal V, Tewhey R, Leproust EM, Schork NJ. Efficient and cost effective population resequencing by pooling and in-solution hybridization. PLoS One 2011; 6: e18353.
38. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-1760.
39. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-249.
40. Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res 2012; 40(Web Server issue): W452-W457.
41. Phillips C. Online resources for SNP analysis: a review and route map. Mol Biotechnol 2007; 35: 65-97.
42. Clarke L, Zheng-Bradley X, Smith R, Kulesha E, Xiao C, Toneva I et al. The 1000 Genomes Project: data management and community access. Nat Methods 2012; 9: 459-462.
43. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
44. Malo N, Libiger O, Schork NJ. Accommodating linkage disequilibrium in genetic-association analyses via ridge regression. Am J Hum Genet 2008; 82: 375-385.
45. Bansal V, Libiger O, Torkamani A, Schork NJ. Statistical analysis strategies for association studies involving rare variants. Nat Rev Genet 2010; 11: 773-785.
46. Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 2011; 364: 524-534.
47. Howie B, Marchini J, Stephens M. Genotype imputation with thousands of genomes. G3 (Bethesda) 2011; 1: 457-470.
48. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet 2010; 11: 499-511.
49. Versini A, Ramoz N, Le Strat Y, Scherag S, Ehrlich S, Boni C et al. Estrogen receptor 1 gene (ESR1) is associated with restrictive anorexia nervosa. Neuropsychopharmacology 2010; 35: 1818-1825.
50. Young JK. Anorexia nervosa and estrogen: current status of the hypothesis. Neurosci Biobehav Rev 2010; 34: 1195-1200.
51. Newman JW, Morisseau C, Hammock BD. Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog Lipid Res 2005; 44: 1-51.
52. Liang L, Morar N, Dixon AL, Lathrop GM, Abecasis GR, Moffatt MF et al. A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome Res 2013; 23: 716-726.
53. Leibowitz SF. Paraventricular nucleus: a primary site mediating adrenergic stimulation of feeding and drinking. Pharmacol Biochem Behav 1978; 8: 163-175.
54. Bhatnagar S, Dallman MF. The paraventricular nucleus of the thalamus alters rhythms in core temperature and energy balance in a state-dependent manner. Brain Res 1999; 851: 66-75.
55. Miller SP, Erickson SJ, Branom C, Steiner H. Habitual response to stress in recovering adolescent anorexic patients. Child Psychiatry Hum Dev 2009; 40: 43-54.
56. Hamani C, Mayberg H, Stone S, Laxton A, Haber S, Lozano AM. The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry 2011; 69: 301-308.
57. Smink FR, van Hoeken D, Hoek HW. Epidemiology of eating disorders: incidence, prevalence and mortality rates. Curr Psychiatry Rep 2012; 14: 406-414.
58. Klump KL, Keel PK, Sisk C, Burt SA. Preliminary evidence that estradiol moderates genetic influences on disordered eating attitudes and behaviors during puberty. Psychol Med Oct 2010; 40: 1745-1753.
59. Sura P, Sura R, Enayetallah AE, Grant DF. Distribution and expression of soluble epoxide hydrolase in human brain. J Histochem Cytochem 2008; 56: 551-559.
60. Rigaud D, Tallonneau I, Verges B. Hypercholesterolaemia in anorexia nervosa: frequency and changes during refeeding. Diabetes Metab 2009; 35: 57-63.
61. Weinbrenner T, Zuger M, Jacoby GE, Herpertz S, Liedtke R, Sudhop T et al. Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholesterolaemia. Br J Nutr 2004; 91: 959-969.
62. Sato K, Emi M, Ezura Y, Fujita Y, Takada D, Ishigami T et al. Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred. J Hum Genet 2004; 49: 29-34.
63. Imig JD. Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev 2012; 92: 101-130.
64. Mertes I, Fleischmann R, Glatt HR, Oesch F. Interindividual variations in the activities of cytosolic and microsomal epoxide hydrolase in human liver. Carcinogenesis 1985; 6: 219-223.
65. Iyer A, Kauter K, Alam MA, Hwang SH, Morisseau C, Hammock BD et al. Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats. Exp Diabetes Res 2012; 2012: 758614.
66. De Taeye BM, Morisseau C, Coyle J, Covington JW, Luria A, Yang J et al. Expression and regulation of soluble epoxide hydrolase in adipose tissue. Obesity (Silver Spring) Mar 18: 489-498.
67. Favaro A, Caregaro L, Di Pascoli L, Brambilla F, Santonastaso P. Total serum cholesterol and suicidality in anorexia nervosa. Psychosom Med 2004; 66: 548-552.
68. Sullivan PF, Joyce PR, Bulik CM, Mulder RT, Oakley-Browne M. Total cholesterol and suicidality in depression. Biol Psychiatry 1994; 36: 472-477.
69. Fornage M, Boerwinkle E, Doris PA, Jacobs D, Liu K, Wong ND. Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: The Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation 2004; 109: 335-339.
70. Lee CR, North KE, Bray MS, Fornage M, Seubert JM, Newman JW et al. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Hum Mol Genet 2006; 15: 1640-1649.
71. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 8: 828-834.
72. Scott-Van Zeeland AA, Abrahams BS, Alvarez-Retuerto AI, Sonnenblick LI, Rudie JD, Ghahremani D et al. Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci Transl Med 2010; 2: 56ra80.
73. Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010; 467: 52-58.